Algernon Pharmaceuticals Inc.

Biotechnology • Healthcare • Vancouver, BC, United States • AGNPF (OQB)

Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. It pipeline includes Ifenprodil, which is in Phase 2b clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in Phase 1 clinical trial for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which is in Phase 1 clinical trial for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc. and changed its name to Algernon Health Inc. in October 2025. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

604 398 4175 601 West Broadway, Vancouver, BC V5Z 4C2, Canada

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Algernon Pharmaceuticals Announces Name Change to Algernon Health - Yahoo Finance

Yahoo Finance • Sep 4

Algernon Pharmaceuticals changes name to Algernon Health - Investing.com

Investing.com • Oct 15

CSE Bulletin: Name Change - Algernon Pharmaceuticals Inc. (AGN) - TMX Newsfile

TMX Newsfile • Oct 16

Pharmaceutical company to launch imaging center chain focused on Alzheimer’s disease - Radiology Business

Radiology Business • May 14

Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals - PR Newswire

PR Newswire • Oct 7

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Algernon Pharmaceuticals Inc. had layoffs?

No layoff events have been recorded for Algernon Pharmaceuticals Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Algernon Pharmaceuticals Inc. in?

Algernon Pharmaceuticals Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Algernon Pharmaceuticals Inc. a publicly traded company?

Yes, Algernon Pharmaceuticals Inc. is publicly traded under the ticker symbol AGNPF on the OQB. The company has a market capitalization of approximately $0.00 billion.

Where is Algernon Pharmaceuticals Inc. headquartered?

Algernon Pharmaceuticals Inc. is headquartered in Vancouver, BC, United States at 601 West Broadway, Vancouver, BC V5Z 4C2, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.